1. Josephson CD. Blood components. In: Hillyer
CD, Strauss RG, Luban NLC, Handbook of Pediatric Transfusion
Medicine. 1st ed. London Academic Press; 2004:3:34-37.
2. Rock G, Poon A, Haddad S, et al. Nutricel as an additive
solution for neonatal transfusion. Transfus Sci.
1999;31:229-235.
3. Luban NLC, Strauss RG, Hume HA. Commentary on the safety
of red cells preserved in extended-storage media for neonatal transfusions.
Transfusion.
1991;31:229-235.
[PubMed: 1900648]
4. Tuchschid P, Mieth D, Burger R, et al. Potential hazard of
hypoalbuminemia in newborn babies after exchange transfusion with
Adsol red blood cell concentrates (letter). Pediatrics.
1990;85:234-235.
5. Brecher ME, ed. Collected Questions and Answers. 6th
ed. Bethesda, MD: AABB; 2000:73-75.
6. Strauss RG, Burmeister LF, Johnson K, et al. Feasibility
and safety of AS-3 red blood cells for neonatal transfusions.
J
Pediatr. 2000;136:215-219.
[PubMed: 10657828]
7. Goodstein MH, Herman JH, Smith JF, et al. Metabolic consequences
in very low birth weight infants transfused with older AS-1 preserved
erythrocytes. Pediatr Pathol Lab Med. 1999;18:173-185.
8. Hume H, Bard H. Small volume red blood cell transfusions
for neonatal patients.
Transfus Med Rev. 1995;9:187-199.
[PubMed: 7549231]
9. Batton DG, Goodrow D, Walker RH. Reducing neonatal transfusion.
J
Perinatol. 1992;12:152-155.
[PubMed: 1522434]
10. Roseff SD, Luban NLC, Manno CS. Guidelines for assessing appropriateness
of pediatric transfusion.
Transfusion. 2002;42:1398-1413.
[PubMed: 12421212]
11. Warwick R, Modi N. Guidelines for the administration of blood
products.
Arch Dis Child. 1995;72:379-381.
[PubMed: 7618900]
12. Voak D, Cann R, Finney RD, et al. Guidelines for administration of
blood products: transfusion of infants and neonates. British Committee
for Standards in Haematology Blood Transfusion Task Force.
Transfus
Med. 1994;4:63-69.
[PubMed: 8012495]
13. Wong CC, Luban NLC. Intrauterine, neonatal, and pediatric transfusion.
In: Mintz PD, ed. Transfusion Therapy: Clinical Principles
and Practice. 2d ed. Bethesda, MD: AABB Press; 2005:159-201.
14. Josephson CD. Neonatal and Pediatric Transfusion
Medicine. Technical Manual. 16th ed. Bethesda, MD: AABB Press;
2008:639-663.
15. AABB Program Standards Committee. Process Control:
Transfusion-Service-Related-Activities. Standards for Blood Banks
and Transfusion Services. 24th ed. Bethesda, MD: AABB Press;
2006:42.
16. Brecher, M. Technical Manual. 14th ed.
Bethesda, MD: AABB; 2002.
17. Luban NLC, Strauss RG, Hume HA. Commentary on the safety
of red cells preserved in extended-storage media for neonatal transfusions.
Transfusion.
1991;31:229-235.
[PubMed: 1900648]
18. Strauss RG, Burmeister LF, Johnson K, et al. AS-1 red cells
for neonatal transfusions: a randomized trial assessing donor exposure and
safety.
Transfusion. 1996;36:873-878.
[PubMed: 8863773]
19. Wang-Rodriguez J, Mannino FL, Liu E, et al. A novel strategy
to limit blood donor exposure and blood waste in multiply transfused premature
infants.
Transfusion. 1996;36:64-70.
[PubMed: 8607157]
20. Liu EA, Mannino FL, Lane TA. Prospective randomized trial of
the safety and efficacy of a limited donor exposure transfusion program
for premature neonates.
J Pediatr. 1994;125:92-96.
[PubMed: 8021796]
21. Bednarek FJ, Weisberger S, Richardson DK, et al. Variations
in blood transfusions among newborn intensive care units.
J
Pediatr. 1998;133:601-607.
[PubMed: 9821414]
22. Maier RF, Sonntag J, Walka MW, et al. Changing practices
of red blood cell transfusions in infants with birth weights less
than 1000 g.
J Pediatr. 2000;136:220-224.
[PubMed: 10657829]
23. Myhre BA, McRuer D. Human error—a significant cause
of transfusion mortality.
Transfusion. 2000;40:879-885.
[PubMed: 10924620]
24. Henry DA, Carless PA, Moxey AJ, O’Connell D, et
al. Pre-operative autologous donation for minimising perioperative
allogeneic blood transfusion [review]. Cochrane
Database Syst Rev. 2003;3.
25. Sharon BI, Honig GR. Management of congenital hemolytic anemias.
In: Simon TL, Dzik WH, Snyder ES, et al, eds. Rossi’s
Principles of Transfusion Medicine. 3d ed. Philadelphia:
Lippencott Williams and Wilkens; 2002:463-482.
26. Cohen AR, Norris CF, Smith-Whitley K. Transfusion therapy
for sickle cell disease. In: Capon SM, Chambers LA, eds. New
Directions in Pediatric Hematology. Bethesda, MD: AABB;
1996:39-88.
27. Adams DM, Schultz WH, Ware RF, Kinney TR. Erythrocytapheresis
can reduce iron overload and prevent the need for chelation therapy
in chronically transfused pediatric patients. J Pediatr
Hematol Oncol. 1996;18:3-7.
28. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first
stroke by transfusions in children with sickle cell anemia and abnormal
results on transcranial Doppler ultrasonography.
N Engl
J Med. 1998;339:5-11.
[PubMed: 9647873]
29. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and
alloimmunization in sickle cell disease.
Blood.
1990;76:1431-1437.
[PubMed: 2207318]
30. Spanos T, Karageorge M, Ladis V, et al. Red cell alloantibodies in
patients with thalassemia.
Vox Sang. 1990;58:50-55.
[PubMed: 2316211]
31. Rosse WF, Telen M, Ware RE. Transfusion Support
for Patients with Sickle Cell Disease. Bethesda, MD: AABB
Press; 1998.
32. Smith-Whitley K. Alloimmunization in patients with sickle
cell disease. In: Herman JK, Manno CS, eds. Pediatric Transfusion
Therapy. Bethesda, MD: AABB Press; 2002:240-282.
33. Ehrenkranz RA. The newborn intensive care unit. In: Oski
FA, et al, eds. Principles and Practice of Pediatrics. 2d
ed. Philadelphia: J.B. Lippincott Company; 1994:19:322.
34. Hoffbrand AV, Al-Refaie F, Davis B, et al. Long-term trial
of
deferiprone in 51 transfusion-dependent iron overload patients.
Blood.
1998;91:295-300.
[PubMed: 9414297]
35. Oliveri NF, Brittenham GM. Iron-chelating therapy and the treatment
of thalassemia. Blood. 1997;89:739-761.
36. Andrew M, Vegh P, Caco C, et al. A randomized, controlled
trial of platelet transfusions in thrombocytopenic premature infants.
J
Pediatr. 1993;123:285-291.
[PubMed: 8345429]
37. Blanchette VS, Kuhne T, Hume H, Hellman J. Platelet transfusion
therapy in newborn infants. Transfus Med Rev. 1995;215-230.
38. Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus
therapeutic platelet transfusion practices in hematology and/or
oncology patients.
Transfusion. 1995;35:498-502.
[PubMed: 7770901]
39. Hanson SR, Slichter SJ. Platelet kinetics in patients with
bone marrow hypoplasia: evidence for a fixed platelet requirement.
Blood.
1985;66:1105-1109.
[PubMed: 4052629]
40. Rebulla P, Finazzi G, Marangoni F, et al. The threshold
for prophylactic platelet transfusions in adults with acute myeloid
leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto.
N
Engl J Med. 1997;337:1870-1875.
[PubMed: 9407153]
41. Wandt H, Frank M, Ehninger G, et al. Safety and cost effectiveness
of a 10 × 10 (9)/L trigger for
prophylactic platelet transfusions compared with the traditional
20 × 10(9)/L trigger: a prospective comparative
trial of 105 patients with acute myeloid leukemia.
Blood.
1998;91:3601-3606.
[PubMed: 9572994]
42. Carr R, Hutton JL, Jenkins JA, et al. Transfusion of ABO
mismatched platelets leads to early platelet refractoriness.
Br
J Haematol. 1990;75:408-413.
[PubMed: 2201403]
43. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions
from ABO-incompatible donors.
Transfusion. 1985;25:60-62.
[PubMed: 2578692]
44. Price TH. Blood center perspective of granulocyte transfusions:
future applications.
J Clin Apher. 1995;10:119-123.
[PubMed: 8582892]
45. Klein HG, Strauss RG, Schiffer CA. Granulocyte transfusion
therapy. Semin Hematol. 1996;33:722-728.
46. Vamvakas EC, Pineda AA. Determinants of the efficacy of prophylactic
granulocyte transfusions: a meta-analysis.
J Clin Apher.
1997;12:74-81.
[PubMed: 9263114]
47. AABB. Standards for Blood Banks and Transfusion
Services. 22nd ed. Bethesda, MD; American Association of
Blood Banks Press; 2003.
48. Chanock SJ, Gorlin JB. Granulocyte transfusions. Time for
a second look.
Infect Dis Clin N Am. 1996;10:327-343.
[PubMed: 8803623]
49. Crosson JT. Massive transfusion.
Clin Lab Med. 1996;16:873-882.
[PubMed: 8974199]
50. Burns J, Capparelli E, Brown J, Newburger J, et al. Intravenous gamma-globulin
treatment and retreatment in Kawasaki disease.
Pediatr Infect
Disease J. 1998;17:1144-1148.
[PubMed: 9877364]
51. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulin-update
for clinicians.
Transfusion. 2003;43:1460-1480.
[PubMed: 14507280]
52. Roback JD, Bray RA, Hillyer CD. Longitudinal monitoring
of WBC subsets in packed RBC units after filtration: implications
for transfusion transmission of infections.
Transfusion.
2000;40:500-506.
[PubMed: 10827250]
53. Fergusson D, Hebert PC, Lee SK, et al. Clinical outcomes
following institution of universal leukoreduction of blood transfusions in
premature infants.
JAMA. 2003;289:1950-1956.
[PubMed: 12697797]
54. Strauss RG. Transfusion therapy in neonates.
Am
J Dis Child. 1991;145:904-911.
[PubMed: 1858728]
55. Gilbert GL, Hayes K, Hudson H, et al. Prevention of transfusion-associated
cytomegalovirus infection in infants by blood filtration to remove
leukocytes. Lancet. 1989;i:1228-1231.
56. Adler SP, Chandrika T, Lawrence L, Baggett J. Cytomegalovirus
infections in neonates acquired by blood transfusions.
Pediatr
Inf Dis. 1983;2:114-118.
[PubMed: 6304663]
57. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of
filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative
blood products for the prevention of transfusion-associated CMV
infection after marrow transplant.
Blood. 1995;86:3598-603.
[PubMed: 7579469]
58. Strauss RG. Data-driven blood banking practices for neonatal RBC
transfusions.
Transfusion. 2000;40:1528-1540.
[PubMed: 11134575]
59. Bradley MT, Milam JD, Anderson DC. Use of deglycerolized
red blood cells to prevent post-transfusion infection with cytomegalovirus
in neonates. J Infect Dis. 1984;150:334-339.
60. Moroff G, Friedman A, Robkin-Kline L, et al. Reduction of
the volume of stored platelet concentrates for use in neonatal patients.
Transfusion.
1984;24:144-146.
[PubMed: 6710587]
61. Webert KE, Kleinman SH, Blajchman MA. Transfusion-related
acute lung injury. In: Hillyer CD, Silberstein LE, Ness PM, et al,
eds. Blood Banking and Transfusion Medicine Basic Principles
and Practice. London Academic Press; 2007:691-700.
62. Eder AF. Transfusion reactions. In: Hillyer CD, Strauss
RG, Luban NLC, eds. Handbook of Pediatric Transfusion Medicine. 1st
ed. London Academic Press; 2004:302.